---
document_datetime: 2023-09-21 17:45:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/avastin-epar-all-authorised-presentations_en.pdf
document_name: avastin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7558889
conversion_datetime: 2025-12-27 17:47:50.949345
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU-Number       | Invented name   | Strength   | Pharmaceutical Form                   | Route of administration   | Packaging   | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|---------------------------------------|---------------------------|-------------|---------------------------|----------------|
| EU/1/04/300/001 | Avastin         | 25 mg/ml   | Concentrate for solution for infusion | Intravenous use           | Vial        | 100 mg/4 ml (25 mg/ml)    | 1 vial         |
| EU/1/04/300/002 | Avastin         | 25 mg/ml   | Concentrate for solution for infusion | Intravenous use           | Vial        | 400 mg/16 ml (25 mg/ml)   | 1 vial         |